SCHEMBL22185228

SCHEMBL22185228

CCc1cc2cc(Cl)cc(F)c2[nH]c1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 6/20 0.43
IDH1 O75874 5/20 0.38
GRIN2D O15399 6/20 0.38
GRIN3B O60391 6/20 0.38
GRIN1 Q05586 6/20 0.38
GRIN2A Q12879 6/20 0.38
GRIN2B Q13224 6/20 0.38
GRIN2C Q14957 6/20 0.38
GRIN3A Q8TCU5 6/20 0.38
PARP1 P09874 1/20 0.36
KCNH2 Q12809 1/20 0.36
DAO P14920 1/20 0.36
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
GAA P10253 1/20 0.35
HSD17B10 Q99714 1/20 0.35
PYGL P06737 1/20 0.35
PYGM P11217 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18744798 0.86 HRH4 (0.40) HRH4IDH1GRIN2DGRIN3BGRIN1
SCHEMBL22198970 0.80 HRH4 (0.45) HRH4IDH1GRIN2DGRIN3BGRIN1
SCHEMBL22185211 0.79 TNF (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL22185229 0.78 IDH1 (0.57) IDH1KDM4EALDH1A1HSD17B10
SCHEMBL18171730 0.77 HRH4 (0.43) HRH4IDH1GRIN2DGRIN3BGRIN1
SCHEMBL22185397 0.77 IDH1 (0.43) IDH1GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL3361624 0.77 DAO (0.58) HRH4DAO
SCHEMBL21549766 0.76 IDH1 (0.49) HRH4IDH1GRIN2DGRIN3BGRIN1
SCHEMBL17601436 0.74 IDH1 (0.47) HRH4IDH1GRIN2DGRIN3BGRIN1
SCHEMBL30064708 0.74 IDH1 (0.47) HRH4IDH1GRIN2DGRIN3BGRIN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) 2020-07-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200206233-A1 HETEROCYCLIC COMPOUNDS AS MUTANT IDH INHIBITORS IDH1, IDH2, IDH3A HRH4 1283/4885IDH1 1/4885GRIN2D 2691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.